Related Experiment Video

Updated: Feb 8, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Peritoneal Metastases from Malignant Mesothelioma

Claire Yue Li1, H Richard Alexander2

  • 1Department of Surgery, New York Presbyterian Hospital, 170 William Street, New York, NY 10038, USA.

Surgical Oncology Clinics of North America
|June 25, 2018
PubMed

Insights

Diffuse malignant peritoneal mesothelioma (MPM) is a rare and fatal cancer. It progresses within the abdomen, often diagnosed late due to vague symptoms, and resists chemotherapy.

Area of Science:

  • Oncology
  • Cancer Research

Background:

  • Diffuse malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer.
  • MPM is characterized by locoregional progression within the abdominal cavity.
  • The disease has a poor prognosis and is often diagnosed at an advanced stage.

Purpose of the Study:

  • To summarize the key characteristics of diffuse malignant peritoneal mesothelioma.
  • To highlight the diagnostic challenges and treatment resistance associated with MPM.

Main Methods:

  • Review of existing literature on malignant peritoneal mesothelioma.
  • Analysis of epidemiological and clinical data for MPM.

Main Results:

  • MPM presents with nonspecific abdominal symptoms, delaying diagnosis.
  • The cancer's locoregional growth pattern contributes to high morbidity and mortality.
  • MPM demonstrates significant resistance to conventional chemotherapy.

Conclusions:

  • MPM is a challenging malignancy with limited treatment options.
  • Early diagnosis and novel therapeutic strategies are crucial for improving outcomes in MPM.
  • Further research is needed to overcome chemotherapy resistance in MPM.
Keywords:
Diffuse malignant peritoneal mesotheliomaEarly postoperative intraperitoneal chemotherapyHyperthermic intraoperative peritoneal chemotherapyOperative cytoreductionPeritoneal metastases

More Related Videos

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K
A Preclinical Murine Model of Hepatic Metastases06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

30.4K

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
848
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.3K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
871
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
534